The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma

被引:6
作者
Yang, Facai [1 ,2 ]
Wu, Changkang [3 ]
Bo, Zhiyuan [4 ]
Xu, Jian [3 ]
Yi, Bin [3 ]
Li, Jingdong [3 ]
Qiu, Yinghe [4 ]
机构
[1] Southeast Univ, Zhongda Hosp, Hepatopancreatobiliary Ctr, Sch Med, Nanjing 210009, Peoples R China
[2] North Sichuan Med Coll, Dept Hepatobiliary Surg, Affiliated Hosp, Nanchong 637000, Peoples R China
[3] North Sichuan Med Coll, Hepatobiliary & Intestine Res Inst, Affiliated Hosp, Dept Hepatobiliary Surg,Hepatobiliary & Pancreat, Nanchong 637000, Peoples R China
[4] Naval Mil Med Univ, Affiliated Hosp 3, Dept Biliary Surg, Shanghai 200438, Peoples R China
基金
中国国家自然科学基金;
关键词
Intrahepatic cholangiocarcinoma; N staging; Lymph node dissection; Lymph node metastasis; PROGNOSTIC-FACTORS; RESECTION; SURVIVAL; TRENDS;
D O I
10.1016/j.asjsur.2021.06.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The aim of this study was to explore the clinical value of lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC). Methods: Clinical and pathological data were collected from 147 ICC patients who attended two tertiary centers over the past 5 years. The patients were classified into two groups: the LND group (group A) and the no-performance LND (NLND) group (group B). Clinical and pathological parameters were compared between the two groups to analyze the impact of LND on the long-term survival time of ICC patients. Results: Of the 147 patients, 54.4% (80) received LND and 42.5% (34/80) of these were found to have lymph node metastasis (LNM). LND did not increase postoperative complications (27.5%, P = 0.354), but postoperative hospital stays were longer (12.2 +/- 6.3 d, P = 0.005) in group A compared with group B (20.9%, 9.5 +/- 3.5 d). The 5-year survival rates of groups A and B are almost similar (21% vs 29%, P = 0.905). The overall survival rate of cN0 (diagnosis obtained by imaging) is better than pN1 (diagnosis obtained by histopathology), but lower than pN0 (all P < 0.05). Compared with NLND, the median survival time of LND patients with T1 has not significantly improved (29.3 vs 35.1 months, P = 0.762), but the patients with T2-4 has been significantly increased (29.0 vs 17.1 months, P = 0.040). Elevated CA19-9 level (HR = 1.764, 95% CI: 1.113-2.795, P = 0.016), vascular invasion (HR = 2.697, 95% CI: 1.103-6.599, P = 0.030), and T category (HR =1.848, 95% CI: 1.059-3.224, P = 0.031) were independent risk factors for poor long-term survival time of the ICC patients (all P values < 0.05). Conclusion: ICC patients with cN0 may have LNM, and the long-term survival time of LNM patients is usually poor. We suggest that patients with ICC may require routine LND, especially those with T2-4 category. (c) 2021 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:376 / 380
页数:5
相关论文
共 25 条
  • [21] Defining the Possible Therapeutic Benefit of Lymphadenectomy Among Patients Undergoing Hepatic Resection for Intrahepatic Cholangiocarcinoma
    Vitale, Alessandro
    Moustafa, Mohamed
    Spolverato, Gaya
    Gani, Faiz
    Cillo, Umberto
    Pawlik, Timothy M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (06) : 685 - 691
  • [22] Intrahepatic Cholangiocarcinoma: expert consensus statement
    Weber, Sharon M.
    Ribero, Dario
    O'Reilly, Eileen M.
    Kokudo, Norihiro
    Miyazaki, Masaru
    Pawlik, Timothy M.
    [J]. HPB, 2015, 17 (08) : 669 - 680
  • [23] Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival
    Wu, Lu
    Tsilimigras, Diamantis I.
    Paredes, Anghela Z.
    Mehta, Rittal
    Hyer, J. Madison
    Merath, Katiuscha
    Sahara, Kota
    Bagante, Fabio
    Beal, Eliza W.
    Shen, Feng
    Pawlik, Timothy M.
    [J]. WORLD JOURNAL OF SURGERY, 2019, 43 (07) : 1777 - 1787
  • [24] Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study
    Yoh, Tomoaki
    Cauchy, Francois
    Le Roy, Bertrand
    Seo, Satoru
    Taura, Kojiro
    Hobeika, Christian
    Dokmak, Safi
    Farges, Oliver
    Gelli, Maximiliano
    Cunha, Antonio Sa
    Adam, Rene
    Uemoto, Shinji
    Soubrane, Olivier
    [J]. SURGERY, 2019, 166 (06) : 975 - 982
  • [25] Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma
    Zhang, X-F
    Chakedis, J.
    Bagante, F.
    Chen, Q.
    Beal, E. W.
    Lv, Y.
    Weiss, M.
    Popescu, I.
    Marques, H. P.
    Aldrighetti, L.
    Maithel, S. K.
    Pulitano, C.
    Bauer, T. W.
    Shen, F.
    Poultsides, G. A.
    Soubrane, O.
    Martel, G.
    Koerkamp, B. Groot
    Guglielmi, A.
    Itaru, E.
    Pawlik, T. M.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (07) : 857 - 866